Verona Pharma (VRP)
VRP Share PerformanceMore
|52 week high||5.2450 15/03/16|
|52 week low||2.2650 21/01/16|
|52 week change||0.8000 (33.68%)|
|4 week volume||34,005,486 26/12/16|
Media for (VRP)
Latest News« previous» nextMore
18/01/2017 - 07:00 RNS
RNS Number: 4091U Verona Pharma PLC 18 January 2017 18 January 2017 FOR RNS RELEASE: THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014. THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN O...
11/01/2017 - 07:00 RNS
RNS Number: 8462T Verona Pharma PLC 11 January 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Verona Pharma Plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acq...
04/01/2017 - 10:16 RNS
RNS Number: 3219T Verona Pharma PLC 04 January 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Verona Pharma plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acqu...
29/12/2016 - 16:40 RNS
Verona Pharma plc (?Verona Pharma? or the ?Company?) Exercise of Options Verona Pharma plc (AIM: VRP), the drug development company focused on first-in-class medicines to treat respiratory diseases, announces that it has issued 2,000,000 new ordinary shares in the capital of the Company (the ?New Shares?) following an exercise of share options by a forme...
23/11/2016 - 09:33 StockMarketWire
Verona Pharma announces that it plans to conduct a registered initial public offering in the US. The number of shares an...
23/11/2016 - 09:17 RNS
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014 Verona Pharma Plans to Conduct Registered Initial Public Offering in the U.S. November 23, 2016, Cardiff ? Verona Pharma plc (AIM: VRP) today announced that it plans to conduct a registered initial public offering in th...
28/10/2016 - 06:00 RNS
RNS Number: 6784N Verona Pharma PLC 28 October 2016 Verona Pharma plc ("Verona Pharma" or the "Company") Exercise of Options The Company announces that it has issued 166,667 new ordinary shares in the capital of the Company (the "New Shares") following an exercise of share options by an employee. Application has been made to the London Stock E...
26/10/2016 - 06:00 RNS
Verona Pharma plc ("Verona Pharma" or the "Company") Verona Pharma receives second Venture and Innovation Award from the Cystic Fibrosis Trust Supports first clinical study in patients to explore potential for RPL554 as a novel treatment for cystic fibrosis New data from pre - clinical studies to be presented at Annual North American Cystic Fibrosis Conf...
|Dividend yield||0 %|
Equity Research (VRP)
Verona Pharma plc
Verona’s £44.7m gross raise removes funding uncertainty, allowing the company to focus on the clinical progress of its respiratory asset RPL554, a dual PDE3/PDE4 inhibitor. RPL554 is in development...
Verona Pharma plc
VRP is developing first-in-class drugs to treat unmet medical needs in respiratory disease. Over the last two years’ VRP has reported positive outcomes from a five stage Phase I/IIa programme which...
Verona Pharma plc
VRP is developing first-in-class drugs that treat unmet medical needs in respiratory disease. RPL554 is being fast-tracked to commercialisation by focusing on a $3.2bn market segment poorly serviced...
- 1 of 2
Latest discussion posts More
“I'm not hoping for a buy out. I'm in for a caca or bust finale with either a multibagger return or burger all. If I wanted a less volatile investment I would have bought ...”▼
“My father died from cold. Enough said. I fully support the business and hope they succeed. That would be a win win, yes?”▼
“If the drug show any chance to be successful, it is likely this company would be bought out and likely candidate comes to my mind is 'Vectura'.”▼
Codes & Symbols
|Symbols||VRP, LSE:VRP, VRP.L, VRP:LN, LON:VRP, XLON:VRP|